Company Data
Fusion Pharmaceuticals Inc.
Ticker
FUSN
Current Price
$21.55
Market Cap
$1.8B
Price Target
Refer to Report
Volume
593
52wk Range
$2.31 - $21.6
Overview
Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer. It develops Targeted Alpha Therapies (TAT) together with its proprietary Fast-Clear linker technology. The firm’s lead product candidate comprises FPI-1434, a monotherapy for the treatment of a variety of cancers; FPI-1966, for the treatment of head and neck and bladder cancers; and FPI-2059 among others.